INTRODUCTION
There is a growing interest in the biological and clinical relevance of creatine feeding both in experimental models and in humans. Thus various tumour cell lines implanted in rodents show a significantly decreased growth rate upon feeding the animals with creatine or creatine analogues (Miller et al., 1993) . Extracellular creatine regulates the expression of a creatine transporter in L6 rat muscle cells (Loike et al., 1988) . In humans, Osbakken et al. (1992) recently observed that creatine, but not cyclocreatine, feeding exerted a protective effect on the heart during a subsequent ischaemia. Furthermore, short duration high-intensity athletic performance may be increased by supplementing the diet of human subjects with 5 g of creatine per day, an effect which was tentatively ascribed to an increased intracellular phosphocreatine (PCr) concentration in the skeletal muscle of these individuals . The latter findings, however, seem to contrast with earlier observations on the rat where creatine administration led to a decreased level of creatine in skeletal muscle (Agostini et al., 1981) ; also performance of endurance exercise was not improved by creatine supplementation in trained subjects (Balsom et al., 1993) .
PCr is synthesized in vivo exclusively through the reversible reaction catalysed by creatine kinase, from creatine and ATP (Bessman and Carpenter, 1985) , whereas creatine itself originates either from the diet or via a two-step de novo biosynthesis pathway present in various organs (Walker, 1979) . There are marked inter-organ and inter-species variations in the enzymic distribution of this biosynthesis (Van Pilsum et al., 1972) . In particular, rodent liver (unlike human liver) lacks the first enzyme involved in creatine synthesis (glycine amidinotransferase), leaving the pancreas and kidneys as major sources for endogenous creatine (Walker, 1963; Koszalka, 1963; Koszalka, 1967) .
There are few data concerning the hepatic transport of creatine, either in vitro (hepatocytes, perfused liver) or in vivo (Henderson ported by a pH-dependent mechanism obeying a saturable Michaelis-Menten type of kinetics (Km = 0.80 + 0.18 and 5.12 + 2.40 mM; V,',ax = 0.57 + 0.04 and 1.72 + 0.32,umol g of liver-' min-' at pH 7.40 and 6.40 respectively). Creatine export was evaluated in the perfused liver preloaded with creatine and the results show that less than 2.5 and 5 % of the total creatine pool is exported to the perfusate during 80 min of perfusion at pH 7.40 and 6.40 respectively. Taken together, these results seem to explain the observation that creatine accumulates in the mouse liver only when blood creatine is raised by creatine feeding.
et Yanokura et al., 1984; Meert et al., 1991) . In perfused liver from transgenic mice (expressing the gene of creatine kinase CKBB isoenzyme in the liver), it has been shown recently that creatine uptake was dependent on the presence of Pi in the perfusate buffer . In the present work, we have undertaken a series of experiments with the same model, investigating the kinetics and quantitative aspects of creatine transport in the liver in vivo and in the perfused liver. A preliminary account of this study has been presented (Masson and Quistorff, 1993) .
EXPERIMENTAL Animals
Transgenic mice expressing the CK BR isoenzyme in the liver (Koretsky et al., 1990) were kindly provided by Dr. Alan Koretsky, University of Pittsburgh, U.S.A. The animals have subsequently been inbred at the Animal Facility of the Panum Institute in the context of an ongoing study of zonation of the mouse liver creatine kinase . Male and female mice, weighing 18-28 g, were fed a regular chow diet or the same diet supplemented with 10 %O (w/w) creatine for 5 days. They had free access to water. Hepatic creatine kinase activity was 5.28 + 0.66 and 4.99 + 0.14 units mg of total protein-' in the male and female mice respectively . Male hybrid mice (strain B6D2F1), which were originally used for the construction of the transgenic mice (Koretsky et al., 1990) , were used as controls in this study, and were obtained from M0llegaard, Denmark.
Liver perfusion
The mice were anaesthetized by intraperitoneal injection of a mixture of sodium pentobarbital (100 mg kg of body weight-') and propanidide (sombrevin, 4 ml kg of body weight-'). The Abbreviations used: PCr, phosphocreatine; pHo, perfusate pH; f.i.d., free induction decay.
* To whom correspondence should be addressed. excised livers (mean weight after dry-blotting: 1.37 + 0.03 g) were perfused via the portal vein in a non-recirculating set-up, at a constant flow rate of 8.0 ml min-'. The perfusion medium was a Krebs-Henseleit buffer equilibrated with 02/C02 (19: 1) passing through a silastic-tubing gas exchanger. The pH of the medium, (pH,) was 7.40 or adjusted to 6.40 by decreasing the amount of NaHCO3 to 2.2 mM. The temperature of the perfusate was 37°C. After an initial equilibration (approx. 20 min), creatine was added to the medium in concentrations ranging over 0.5-15 mM. The perfusions were concluded after 80 min and the livers were rapidly freeze-clamped (Quistorff and Poulsen, 1980) and stored at -80°C until analysed. Removal of the liver from the perfusion set-up, dry-blotting and freeze-clamping was accomplished in 5-10 s. (Desmoulin et al., 1987) . The concentration of creatine was determined at the end of the experiments in freeze-clamped biopsies by biochemical analysis and expressed as ,umol g wet wt of liver'. When relevant these data were corrected for the contribution of the extracellular space, multiplying by 1/0.83, i.e. uamol ml of liver cells-u (Weibel et al., 1969 
Biochemical analyses
Hepatic metabolites were extracted with 2 M perchloric acid as previously described (Masson and Quistorff, 1992) . Standard enzymic assays were used to measure ATP, PCr and creatine (Lowry and Passonneau, 1972) , and a colorimetric assay for Pi (Penney, 1976) . Hepatic creatine kinase activity was measured as described by Bergmeyer (1970) .
Statistics
Data are presented as means + S.E.M. for the number of observations stated. Statistical analysis was performed using a two-tailed Student's t test, and the level of significance was set at P < 0.05 (C-Stat software package, Cherwell Scientific Publishing, Oxford, UK.). The kinetics were analysed with a curve-fitting program (GraphPad InPlot software, GraphPad Software, San Diego, CA, U.S.A.).
At the completion of the perfusion (80 min), the liver was freeze-clamped and the intracellular concentrations of creatine and PCr were measured, assuming an extracellular space of 15 % of the biopsy wet weight. These results are given in Table 2 . Excellent correlation was observed between the n.m.r. and the biochemical determination of PCr, indicating 100 % visibility for this compound in the liver, in agreement with earlier observations in vivo in the liver (Koretsky et al., 1990) and muscle (Bangsbo et al., 1993) . The intracellular/extracellular concentration gradient of creatine diminished with increasing extracellular creatine concentration. Thus, at pHo 7.40 the gradient decreased 2-fold when increasing the perfusate creatine concentration from 0.5 to 5.0 mM. At pHo 6.40, the creatine uptake rate was lower than at pHo 7.40 (see below) and an additional series of experiments with a perfusate creatine concentration of 15 mM was therefore 4 RESULTS Effect of creatine feeding in vivo Table 1 shows the concentrations of creatine, PCr and ATP in liver and in portal blood sampled from the anaesthetized mouse in vivo. The animals had been fed either regular chow or the same diet supplemented with I0O% (w/w) creatine for 5 days. The creatine feeding resulted in a 5-14-fold increase in the creatine concentration measured in the portal blood, significantly higher in the transgenic than in the control mice. Portal blood and a liver biopsy were sampled from the same animal. In the practical experiment, however, it was necessary to withdraw the blood before sampling the liver biopsy, introducing a brief ischaemia during blood sampling, which caused some hydrolysis of PCr in the liver. For this reason, only total creatine [PCr + Cr] was taken into consideration in the quantitative evaluation of these data. In the liver biopsies of regularly fed animals, the total creatine concentration was of the order of 0.6 mM with no difference between control and transgenic mice. However, upon creatine feeding, the total creatine content increased more than 10 times in the controls and 36 times in the transgenic mice. ATP concentration in the biopsy samples was about 2.5 mM in controls and 3 mM in transgenic mice, with no significant effect of creatine feeding. Taken together, these results suggest that an active uptake mechanism for creatine in the mouse liver is in operation.
Kinetics of creatine transport in the perfused liver
In order to describe creatine transport in quantitative terms, we therefore perfused mouse livers with different concentrations of creatine in the perfusate (ranging over 0-15 mM). Furthermore, these experiments were carried out at perfusate pH values of 7.40 and 6.40. The perfusions were performed with continuous recording of 31P-n.m.r. spectra, allowing the direct measurement of PCr accumulation as well as changes of intracellular pH. A typical 31P-n.m.r. spectrum of the liver of a transgenic mouse fed a regular diet is presented in Figure 1 (a). Figure 1( The liver from a mouse transfected with the gene for creatine kinase BB was perfused and 31p_ n.m.r. spectra acquired as described in the Experimental section. The animal was fed a regular chow. Trace (a) corresponds to a control spectrum, recorded after 20 min of perfusion with a Krebs-Henseleit buffer. Trace (b) has been recorded on the same liver, after 80 min of infusion with 5.0 mM creatine at pHo 7.40. Assignments of resonance: 1, phosphomonoesters (mainly phosphorylcholine and AMP); 2, inorganic phosphate (P); 3, phosphodiesters (glycerol 3-phosphoethanolamine and glycerol 3-phosphocholine); 4, phosphocreatine; 5,y-phosphorus of NTP and f8-phosphorus of NDP; 6, a-phosphorus of NTP, a-phosphorus of NDP and NAD+; 7, ,-phosphorus of NTP. undertaken. In analogy with the data at pHo 7.40, the intracellular/extracellular gradient was decreased from 2.2 to 1.36 when creatine concentration in the medium was increased from 2.0 mM to 15 mM. The intracellular PCr/creatine ratio determined after 80 min was about 0.7 at pHo 7.40, decreasing only slightly with increasing creatine concentration. However, at pHo 6.40, the PCr/creatine ratio decreased very significantly as expected from the decreased intracellular pH. In fact, taking into account the effect of lowered pH on the equilibrium of the creatine kinase reaction (Lawson and Veech, 1979) , and the observed decrease in intracellular pH (from 7.20 + 0.05 to 6.70 + 0.05), the expected change in the intracellular PCr/creatine ratio may be calculated to be 3.2-fold, which is in good agreement with the observed value (see Table 2 Alternatively, creatine efflux was evaluated in perfused livers preloaded with creatine by imposing a rapid transient depletion of intracellular PCr and thereby a corresponding increase in the intracellular creatine concentration. This procedure was accomplished by adding fructose to the perfusate as suggested by Brosnan et al. (1991) . Figure 3(a) shows the time course of PCr with a time resolution of 1 min during a 10 mM fructose infusion, as well as the recovery phase after discontinuation of the fructose infusion. The initial level of PCr was 12.06,mol g of liver-' (100 %) and decreased to 18.5 + 3.8 % (n = 10) during the 15 min of fructose infusion. The rate constant of this decay was 0.27 + 0.03 min-'. Removal of fructose led to a full recovery of PCr (99.3 + 5 %) with a rate constant of 0.27 + 0.04 min-'. However, the PCr level decreased somewhat thereafter, reaching 94.11 + 4.27 %, 20 min after the withdrawal of fructose. In separate experiments with the same protocol the PCr/Cr ratio was determined biochemically in biopsies sampled in the beginning before fructose infusion (1.41 + 0.32) and at the end of the experiment after recovery from fructose (1.38+0.40; n = 3). These figures are not significantly different, and consequently the complete recovery of PCr in the n.m.r. experiment indicates that there is no significant loss of creatine during the 80 min perfusion interval.
In a second set of experiments, perfused livers underwent the same protocol as described above, except that 5 mM creatine was co-infused with fructose (10 mM). During recovery, both creatine and fructose were omitted from the buffer. Figure 3( (Figure  3b ), indicating a significant creatine uptake during the interval when both fructose and creatine were present in the perfusate. 
DISCUSSION
It has been shown that PCr accumulation in the transgenic mouse liver depended on prior supplementation of the food with high amounts of creatine [10 % (w/w) of the diet] for several days (Koretsky et al., 1990) . In a recent study aimed at examining the possible zonation of the artificially induced creatine kinase , we observed that total creatine content ([PCr + Cr]) in the liver of both normal and transgenic mice was highly variable when the animals were on the creatine feeding schedule mentioned above. Prompted by this observation we decided to investigate the kinetics of creatine uptake in the perfused mouse liver.
Creatine synthesis in human and rodents
Creatine is either derived directly from the diet (e.g. in meat) or synthesized in several organs from amino acids in a two-step process. In the first step, guanidoacetate is formed from arginine and glycine in a reaction catalysed by an amidinotransferase (EC 2.1.4.1.; Walker, 1979) . This enzyme is co-repressed by creatine and some ofits synthetic analogues (Roberts and Walker, 1985) , and displays vastly different distributions between species and organs. In human, the pancreas appears to be the most active organ for creatine biosynthesis, more so than liver and kidney (Walker, 1963; Van Pilsum et al., 1972) . Muscle and brain tissues are not competent for creatine synthesis, but rely on PCr for their energy metabolism. The situation is different in rodents where the liver apparently lacks the amidinotransferase (Walker, 1963; Van Pilsum et al., 1972) , which leave the pancreas and the kidneys as the main sources of guanidinoacetate (Koszalka, 1967) . In general, it seems that organs capable of de novo creatine synthesis do not express creatine kinase significantly and vice versa (Van Pilsum et al., 1972; Yanokura and Tsukada, 1982 ) although this appears not to be the case for the rodent liver.
Creatine concentration varies significantly between species and in different organs. Blood creatine is reported to be 0.14-0.16 mM in rats (Fitch and Shields, 1966; Meert et al., 1991) , 0.24 +0.03 mM in mice (Kim et al., 1983) and as low as 40 + 1 luM in the plasma of healthy human (Mussini et al., 1984) .
In the portal blood of normal and transgenic mice, we found creatine concentrations of 65 + 9 and 53 + 13,M respectively (Table 1) . Highly variable concentrations ofcreatine are similarly reported in rodent muscle tissues, ranging from 3 to 30,umol g wet weight-' (Haughland and Chang, 1975; Kim et al., 1983; Yanokura et al., 1984; Reddy et al., 1992; Brosnan et al., 1993) . On the other hand, rodent liver contains much lower creatine, Table 3 Kinetic parameters of creatine transport In perfused liver from transgenic mouse
The data are calculated from the progress curves of PCr accumulation (Figure 2 ) at different concentrations of creatine, after conversion into total creatine content (see the Experimental section).
The initial rates of creatine uptake were calculated for each concentration of infused creatine and each perausate pH. Vr,, and Km were computed from these initial rates and the perfusate concentration of creatine assuming a Michaelis-Menten type of kinetics. Figure 3 Evolution of hepatic PCr during fructose infusion to perfused livers from transgenic mice fed a diet supplemented with creatine Transgenic mice were fed for 5 days with a diet supplemented with 10% (w/w) creatine. Livers were first perfused for 20 min with a Krebs-Henseleit buffer (pHo 7.40). At time zero, either 10 mM fructose (a) or 10 mM fructose plus 5 mM creatine (b) were added to the medium. After 15 min, fructose or fructose +creatine infusion was discontinued. 3P-.r setawe recorded every 2 min and the evolution of PCr is presented. Data are means+S.E.M. for ten experiments (fructose infusion alone) or three experiments (co-infusion of fructose and creatine). ranging over 0.16-0.53 pumol g wet weight-l (Yanokura and Tsukuda, 1982; Yanokura et al., 1984; Meert et al., 1991; Reddy et al., 1992) , in accordance with the present results (0.48+0.08 and 0.50 + 0.05,utM in control and transgenic mice respectively).-It is therefore obvious that the gradient of total creatine across the plasma membrane is much higher in muscle than in liver tissues. For instance, this gradient amounts to 48-fold in the sheep biceps femoris but is only 5-fold in the liver of the same animal (Henderson et al., 1983) . In the perfused rat heart the gradient is about 100-fold (Seppet et al., 1985) and 45-fold in fibroblasts (Daly and Seifter, 1980) . Accordingly, we found a gradient of total creatine in the mouse liver in vivo of about 8-fold (Table I1 ).
In the present study, the portal concentration of creatine was increased 5-15 times by the creatine feeding protocol (see Table  1 ). However, the evaluation of the creatine concentration in the portal blood was based on only one time point, after approx. 6 h into the light period of a 12 h/ 12 h alternate dark/light circadian cycle. It is therefore possible that the blood creatine concentration could have been significantly higher at an earlier time point. In fact, this would seem to be the only explanation for the very high concentrations of total creatine reached in the transgenic animals subjected to creatine feeding (20.8 mM, see Table 1) , since it appears from the perfusion experiments that the maximal attainable intracellular/extracellular creatine concentration gradient is of the order of 2-3-fold. Furthermore, as explained in the Results section, it is likely that the creatine concentration measured in the liver biopsies taken in vivo is too high due to unavoidable hydrolysis of PCr in the interval between blood sampling from the portal vein and freeze-clamping of the liver.
The fact that PCr is present in the liver of control mice fed with creatine in significant amounts (see Table 1 ), even though creatine kinase does not appear to be expressed in the hepatocytes (except perhaps for a low activity of the mitochondrial enzyme CKm), can probably be accounted for by significant activity of CKBB in sinusoidal and Kupffer cells (Vaubourdolle et al., 1993) .
Transport of creatine into the perfused mouse liver
Transport of creatine across the plasma membrane has mainly been investigated in tissues relying on creatine uptake for their synthesis of PCr, such as skeletal muscle, heart and brain. In these organs, creatine is co-transported with sodium ions by a saturable process with a Km of the order of 50,uM, matching the systemic creatine concentration in the rat (Seppet et al., 1985) . Such transporters have been described in fibroblasts and smooth muscle cell lines (Daly and Seifter, 1980) or in the human muscle cell line L6 (Loike et al., 1988) . However, a much higher Km of 0.5-0.6 mM has been found in the rat extensor digitorum longus muscle (Fitch and Shields, 1966; Haughland and Chang, 1975) . Recently, the cDNA for a creatine transporter has been cloned and shown to depend upon Na+ and Cl-ions for its activity. In the rabbit, this carrier was mainly expressed in kidney, brain, heart and skeletal muscle, but remained undetectable in the liver (Guimbal and Kilimann, 1993) . Creatine transport is modulated by (i) the hormonal (Haughland and Chang, 1975) and feeding states of the animal (Kim et al., 1983) ; (ii) the presence of Pi in the perfusion medium as shown in rabbit heart (Gitomer et al., 1992) , and (iii) is downregulated by a physiological concentration of creatine (Loike et al., 1988) . In addition to the saturable creatine uptake process, a non-saturable mechanism has been described in red blood cells (Syllm-Rapoport et al., 1980) , which, however, appears to account for only a small fraction of the total creatine uptake in skeletal muscle (Fitch and Shields, 1966; Haughland and Chang, 1975; Kim et al., 1983) , heart (Seppet et al., 1985) , smooth muscle cell lines (Daly and Seifter, 1980) , monocytes and macrophages (Loike et al., 1986) .
Creatine transport has not previously been studied in the rodent liver and in the present study we have demonstrated that creatine is transported by an active, saturable mechanism strongly dependent on extracellular pH. At an external pH of 7.40, the Km value of creatine transport was 0.80 + 0.18 mM ( Pi plays a role in creatine transport. Indeed, removing P, from the perfusion buffer increased the intracellular content of creatine in rabbit heart, presumably through a decrease of creatine efflux mediated by an enhanced sodium electrochemical gradient across the plasma membrane (Gitomer et al., 1992) . Similarly in the perfused liver from transgenic mice omission of Pi from the perfusate induced a very significant decrease ofPCr accumulation . In the present study, we have found that decreasing the pH of the perfusion increased both Km and Vm'ax for creatine transport (Table 3) . It is not clear whether these changes may be explained as secondary effects of pH on the electrochemical sodium gradient.
Efflux of creatine from the liver The liver of higher mammals synthesizes creatine from amino acids and exports it to other organs dependent on PCr for their energy metabolism (Walker, 1979) . This would seem to require an efficient process of creatine excretion. However, rodent liver lacks arginine: glycine amidinotransferase, the first of the two enzymes involved in de novo synthesis of creatine and in those animals creatine is mainly synthesized in the kidneys and the pancreas (Van Pilsum et al., 1972) . Since the rodent liver does not appear to synthesize creatine, it was of interest to investigate the creatine efflux capacity from the perfused liver. Two series of experiments were conducted in order to evaluate creatine efflux. In the first series, the mice were fed for 5 days with a diet supplemented with creatine to induce an hepatic accumulation of PCr (12.06 + 0.1 1 ,umol g of liver-'). Since a non-recirculating perfusion set-up was used, the fact that no significant decrease of total creatine could be observed during 80 min of perfusion (see Figure 3) , would seem to corroborate the notion that the mouse liver does not contribute significantly to body creatine synthesis.
This conclusion was further confirmed with the second series of experiments where a rapid PCr depletion (and concomitant creatine increase) was elicited by fructose infusion, again with no significant export of creatine (Figure 3 ). These results are in agreement with other investigators who found a very limited efflux of creatine from human macrophage (Loike et al., 1986) , isolated rat heart (O'Brien and Nutbeam, 1976) or atria (Savabi, 1988) . Similarly, perfused rat hearts acutely preloaded with /,-guanidinopropionic acid (an analogue of creatine and a competitive inhibitor of its transport) do not display a decrease of the infused without the guanidine compound, suggesting a very limited efflux in these conditions (Unitt et al., 1993) . To the best of our knowledge, there have been no investigations of creatine efflux from the liver of higher animals, which is supposed to export creatine. Creatine efflux from skeletal muscle is also very limited (Fitch and Shields, 1966) although increased by fasting (Kim et al., 1983) or tri-iodothyronine-induced hyperthyroidism (Kurahashi and Kuroshima, 1977 
